It depends on what is already close. Pages sitting at positions 11 to 40 for commercial terms can move within weeks when targeting, internal links, links and, where suitable, a push are applied together. New category and money pages take one to two quarters to earn authority. Topical depth, brand SERP strength and answer-engine citation compound over a year. All three tracks run from month one; nobody can promise a date for a ranking.
Weeks: near-wins
In the case study, a flagship product page went from 37 to page one within a week of a push launched on day 16 of the retainer, then settled in the top 15 as the durable work continued. The conditions were specific: real demand, weak competition, an existing page with some authority, and a client whose compliance perimeter allowed the page to be improved. Where those conditions exist, the first month can produce revenue. Where they do not, the first month produces the map.
A quarter: money-page architecture and authority
New product, category and supplier-discovery pages need links and internal links before they compete. Editorial placements in this category are slower to secure than in mainstream ecommerce because publishers are cautious, so a quarter is a fair horizon for a new page to reach the top 30.
A year: the moat
Research-framed content depth, documentation pages, brand SERP strength and the citations that make answer engines name a vendor accumulate over a year. This is the part competitors cannot buy quickly, and the part that survives platform changes.
What slows it down
- A compliance perimeter that has not been written down, so every page waits on a review.
- Dependence on one compound whose status can change.
- Platform migrations without a redirect map.
- Links bought for volume that publishers later remove.
What we do not say
We do not promise page one, a date, or a traffic figure. Results on this site are individual, dated and reported as stated.
PeptidesSEO provides search-marketing services and publishes search-marketing analysis. We are not physicians, pharmacists, lawyers or regulatory consultants, and nothing on this site is medical, legal or regulatory advice. Clients remain responsible for obtaining qualified advice about their products, claims, jurisdictions and operations.